Bayer extends CEO Bill Anderson contract until 2029
Leverkusen: The Supervisory Board of Bayer AG has unanimously decided to extend the contract of CEO Bill Anderson until March 31, 2029. His contract was originally set to end on March 31, 2026. Anderson joined Bayer on April 1, 2023, and became CEO on June 1, 2023.
“Bayer is in the middle of a far-reaching transformation,” said Prof. Dr. Norbert Winkeljohann, Chairman of the Supervisory Board of Bayer AG. “Bill Anderson is charting the right course and has initiated a comprehensive turnaround program in an important phase for Bayer. Under his leadership, the company will resolutely continue this path,” said Winkeljohann.
Anderson believes the company is making good progress. Bayer has numerous opportunities to capitalize on, as well as some serious challenges that it is diligently addressing, he said.
“With our mission of ‘Health for all, Hunger for none’, we serve the needs of people all around the world. That’s what motivates my colleagues – and it’s also something that inspires me each and every day. I truly believe that our team has the right focus and the right plan to become the leanest, fastest, and most innovative life science company. Team Bayer is all in and we are totally up to the task. I’m delighted to be a part of Team Bayer and I’d like to thank the members of the Supervisory Board – the stockholder and employee representatives alike – for the trust they have placed in me,” Anderson said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.